BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1961287)

  • 1. A patient review of the ESRD program: Part II.
    Nephrol News Issues; 1991 May; 5(5):18-24, 27. PubMed ID: 1961287
    [No Abstract]   [Full Text] [Related]  

  • 2. A patient review of the ESRD program: Part I.
    Nephrol News Issues; 1991 Apr; 5(4):22-7. PubMed ID: 1961282
    [No Abstract]   [Full Text] [Related]  

  • 3. IOM study released; calls for up to $640 million more for ESRD, transplant patients.
    Nephrol News Issues; 1991 May; 5(5):11, 14-6. PubMed ID: 1961285
    [No Abstract]   [Full Text] [Related]  

  • 4. Trying to measure quality? Ask the patient.
    Sadler JH
    Nephrol News Issues; 1996 Oct; 10(10):19, 28. PubMed ID: 9025494
    [No Abstract]   [Full Text] [Related]  

  • 5. The IOM report: an A+ for effort, but will it survive Washington's budget-cutting mood?
    Hull AR
    Nephrol News Issues; 1991 May; 5(5):28-9. PubMed ID: 1961288
    [No Abstract]   [Full Text] [Related]  

  • 6. Delivery of care.
    Cooper L
    Nephrol News Issues; 2002 Aug; 16(9):62-3, 66. PubMed ID: 12229098
    [No Abstract]   [Full Text] [Related]  

  • 7. The ESRD regulatory landscape: a primer & resource. Part 2.
    Robers S
    Nephrol News Issues; 2003 Jan; 17(2):22-5. PubMed ID: 12629824
    [No Abstract]   [Full Text] [Related]  

  • 8. Hazards to patients in a teaching hospital.
    Hershkowitz M
    Med Health R I; 2006 Nov; 89(11):368-9. PubMed ID: 17168086
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicare cuts: hopefully gone, but more likely, not forgotten (by Washington).
    Rubin R
    Nephrol News Issues; 1991 Apr; 5(4):16-7. PubMed ID: 1961278
    [No Abstract]   [Full Text] [Related]  

  • 10. A fresh approach to measuring quality care.
    Neumann ME
    Nephrol News Issues; 1991 Jun; 5(6):5, 55. PubMed ID: 1961304
    [No Abstract]   [Full Text] [Related]  

  • 11. New dialysis-specific COOP charts may improve ESRD patient assessment.
    Sadler JH; Blagg CR; Wasson JH
    Nephrol News Issues; 1998 Sep; 12(9):41-2. PubMed ID: 9923296
    [No Abstract]   [Full Text] [Related]  

  • 12. Rate reductions could affect patient outcomes, study says.
    Wagner L
    Mod Healthc; 1991 Apr; 21(16):12. PubMed ID: 10110117
    [No Abstract]   [Full Text] [Related]  

  • 13. Measuring and improving the health status of end stage renal disease patients.
    Rettig RA; Sadler JH
    Health Care Financ Rev; 1997; 18(4):77-82. PubMed ID: 10175614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying the IOM perspective to the networks' approach to QA.
    McClellan W
    Nephrol News Issues; 1992 Feb; 6(2):44-6. PubMed ID: 1557154
    [No Abstract]   [Full Text] [Related]  

  • 15. Is it time again for patient selection criteria?
    Price CA
    Nephrol News Issues; 1992 Feb; 6(2):18-20. PubMed ID: 1290483
    [No Abstract]   [Full Text] [Related]  

  • 16. An IOM view: ethical issues in dialytic care need addressing.
    Rettig RA; Cassel CK; Moss AH
    Nephrol News Issues; 1992 Feb; 6(2):21-3. PubMed ID: 1557143
    [No Abstract]   [Full Text] [Related]  

  • 17. Managed care is not the "cure-all" for improving quality and controlling costs in ESRD.
    Amerling R
    Nephrol News Issues; 1999 Apr; 13(4):46-7. PubMed ID: 10418448
    [No Abstract]   [Full Text] [Related]  

  • 18. The IOM report unequal treatment: lessons for clinical practice.
    Betancourt JR; Maina AW; Soni SM
    Del Med J; 2005 Sep; 77(9):339-48. PubMed ID: 16231664
    [No Abstract]   [Full Text] [Related]  

  • 19. IOM highlights health disparities: implications for health plans.
    Betancourt JR
    Healthplan; 2002; 43(4):30-3, 36. PubMed ID: 12221774
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction in ESRD reimbursement rate: identifying research priorities and quality indicators.
    Parker J
    ANNA J; 1990 Apr; 17(2):147-54. PubMed ID: 2183724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.